Clinical trial begins for Chikungunya Vaccine # short stories

New Delhi :  Bharat Biotech said on Monday that the first phase of human clinical trial of the indigenously  developed chikungunya vaccine is underway in India to evaluate its safety, tolerability and immunogenicity. According to a press release issued by the vaccine maker, the ” placebo-controlled” study, involved 60 healthy volunteers, would test escalating doses of the vaccine.

 

# short stories

For more updates and latest news, please subscribe Newspaper Cuttings.

Follow us :

Leave a Reply

Your email address will not be published. Required fields are marked *